                         SEQUENCE LISTING

<110>  BCN PEPTIDES, S.A.
 
<120>  Peptides for the treatment of cancer and/or metastasis

<130>  RA

<150>  EP 19383084.1
<151>  2019-12-05

<160>  10    

<170>  PatentIn version 3.5

<210>  1
<211>  96
<212>  PRT
<213>  Homo Sapiens ADAM-12, Disintegrin domain

<400>  1

Glu Val Arg Glu Ser Phe Gly Gly Gln Lys Cys Gly Asn Arg Phe Val 
1               5                   10                  15      


Glu Glu Gly Glu Glu Cys Asp Cys Gly Glu Pro Glu Glu Cys Met Asn 
            20                  25                  30          


Arg Cys Cys Asn Ala Thr Thr Cys Thr Leu Lys Pro Asp Ala Val Cys 
        35                  40                  45              


Ala His Gly Leu Cys Cys Glu Asp Cys Gln Leu Lys Pro Ala Gly Thr 
    50                  55                  60                  


Ala Cys Arg Asp Ser Ser Asn Ser Cys Asp Leu Pro Glu Phe Cys Thr 
65                  70                  75                  80  


Gly Ala Ser Pro His Cys Pro Ala Asn Val Tyr Leu His Asp Gly His 
                85                  90                  95      


<210>  2
<211>  14
<212>  PRT
<213>  Homo Sapiens ADAM-12, sequence from the disintegrin domain

<400>  2

Cys Arg Asp Ser Ser Asn Ser Cys Asp Leu Pro Glu Phe Cys 
1               5                   10                  


<210>  3
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  VARIANT
<222>  (12)..(12)
<223>  Xaa is 2,4,6-trimethylphenylalanine (Msa)

<400>  3

Arg Asp Ser Ser Asn Ser Cys Asp Leu Pro Glu Xaa 
1               5                   10          


<210>  4
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  Xaa is pyroglutamic acid (Pyr)

<220>
<221>  VARIANT
<222>  (13)..(13)
<223>  Xaa is 2,4,6-trimethylphenylalanine (Msa)

<400>  4

Xaa Arg Asp Ser Ser Asn Ser Cys Asp Leu Pro Glu Xaa 
1               5                   10              


<210>  5
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  VARIANT
<222>  (13)..(13)
<223>  Xaa is 2,4,6-trimethylphenylalanine (Msa)

<400>  5

Lys Arg Asp Ser Ser Asn Ser Cys Asp Leu Pro Glu Xaa Lys 
1               5                   10                  


<210>  6
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  Xaa is pyroglutamic acid (Pyr)

<220>
<221>  VARIANT
<222>  (14)..(14)
<223>  Xaa is 2,4,6-trimethylphenylalanine (Msa)

<400>  6

Xaa Lys Arg Asp Ser Ser Asn Ser Cys Asp Leu Pro Glu Xaa Lys 
1               5                   10                  15  


<210>  7
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  Xaa is pyroglutamic acid (Pyr)

<220>
<221>  VARIANT
<222>  (14)..(14)
<223>  Xaa is 2,4,6-trimethylphenylalanine (Msa)

<400>  7

Xaa Lys Arg Asp Ser Ser Asn Ser Met Asp Leu Pro Glu Xaa Lys 
1               5                   10                  15  


<210>  8
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  VARIANT
<222>  (13)..(13)
<223>  Xaa is 2,4,6-trimethylphenylalanine (Msa)

<400>  8

Lys Arg Asp Ser Ser Asn Ser Met Asp Leu Pro Glu Xaa Lys 
1               5                   10                  


<210>  9
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  Xaa is pyroglutamic acid (Pyr)

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  Xaa is Cystine, Cys(Cys)

<220>
<221>  VARIANT
<222>  (14)..(14)
<223>  Xaa is 2,4,6-trimethylphenylalanine (Msa)

<400>  9

Xaa Lys Arg Asp Ser Ser Asn Ser Xaa Asp Leu Pro Glu Xaa Lys 
1               5                   10                  15  


<210>  10
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  10

Arg Asp Ser Ser Asn Ser Cys Asp Leu Pro Glu Phe 
1               5                   10          


